CRISPR/Cas9 treatment allowed mice to live 25% longer and be physically stronger. Biologists see these results being relatively easy to reproduce on humans in a clinical setting.
Category: biotech/medical – Page 1,568
Cell-Intrinsic Learning And Memory Storage Dynamics — Dr. David Glanzman Ph.D., Professor, in the Department Integrative Biology and Physiology, at UCLA College of the Life Sciences.
Dr. David Glanzman is Professor, in the Department Integrative Biology and Physiology, at UCLA College of the Life Sciences, Professor in the Department of Neurobiology in the David Geffen School of Medicine, and Member, Brain Research Institute.
Dr. Glanzman has a B.A. in Psychology from Indiana University Bloomington and a Ph.D. in Psychology from Stanford University.
Dr. Glanzman is interested in the cell biology of learning and memory in simple organisms.
In Dr. Glanzman’s lab research they use two animals, the marine snail Aplysia californica, and the zebrafish (Danio rerio).
If an opinion poll were taken for the most popular component of mammalian cells, the result probably would be a 50–50 split: Half of respondents would likely vote hands down for the nucleus and the other half for the mitochondria—a decision that in no way diminishes or casts aspersions on the other hardworking constituents of cells.
In this special episode of Hello World, best-selling author and Bloomberg Businessweek journalist Ashlee Vance goes on a RV road trip through California in the midst of a pandemic and sweeping forest fires. Along the way, he hangs out with a Tesla co-founder who wants to recycle all the world’s batteries, some robotic farmers, a test pilot who almost lost his life and desert space-geeks building a lunar lander.
#HelloWorld #BloombergBusinessweek #California.
——-
Like this video? Subscribe: https://www.youtube.com/Bloomberg?sub_confirmation=1
QuickTake Originals is Bloomberg’s official premium video channel. We bring you insights and analysis from business, science, and technology experts who are shaping our future. We’re home to Hello World, Giant Leap, Storylines, and the series powering CityLab, Bloomberg Businessweek, Bloomberg Green, and much more.
Subscribe for business news, but not as you’ve known it: exclusive interviews, fascinating profiles, data-driven analysis, and the latest in tech innovation from around the world.
Visit our partner channel QuickTake News for breaking global news and insight in an instant.
A team of Australian researchers believe they have taken a significant step towards unlocking the regenerative power of the stem cells in our bodies.
Despite great advances in the field of intensive care, when patients survive a severe.
Brain injury but remain in a chronic Vegetative State (VS) or Minimally Conscious.
State (MCS) (i.e., a disorder of consciousness; DOC), little can be done to promote.
Recovery [1]. To date, several restorative strategies have been investigated in DOC.
Circulating branched-chain amino acids (BCAAs) are elevated in obesity and diabetes, and recent studies support a causal role for BCAAs in insulin resistance and defective glycemic control. The physiological mechanisms underlying BCAA regulation are poorly understood. Here we show that insulin signaling in the mediobasal hypothalamus (MBH) of rats is mandatory for lowering plasma BCAAs, most probably by inducing hepatic BCAA catabolism. Insulin receptor deletion only in agouti-related protein (AgRP)–expressing neurons (AgRP neurons) in the MBH impaired hepatic BCAA breakdown and suppression of plasma BCAAs during hyperinsulinemic clamps in mice. In support of this, chemogenetic stimulation of AgRP neurons in the absence of food significantly raised plasma BCAAs and impaired hepatic BCAA degradation.
2 things I like here. 1. Aubrey says not only does he think the first person to live to 1000 may be alive today but that they are already middle aged(Like me!). 2. In 15 years we might give a 70 year old treatment that will not make them 20 again, but perhaps it will make them 40. then by the time they hit 70 again the treatments available will be even better.
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501©(3) biomedical research charity that performs and funds laboratory research dedicated to combating aging. In addition, he is Editor-in-Chief of Rejuvenation Research, the world’s highest-impact peer-reviewed journal focused on intervention in aging. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association, and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40–50 invited talks per year at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public. Topics Discussed: Brief overview of SENS
- Why try to end aging?
- How soon do you think we will end aging?
- What role does rejuvenation biotech play in the COVID-19 pandemic? How would regenerative medicine help us better cope with the pandemic?
- How are you implementing the techniques you research in your own life?
- Which breakthrough are you most proud of?Aubrey’s Links: LinkedIn: https://www.linkedin.com/in/aubrey-de-grey-24260b/
Personal Website: https://www.sens.org/
Company Website: https://www.mfoundation.org/
Twitter: https://twitter.com/aubreydegreyListen to the audio version at: https://www.buzzsprout.com/765170/7722976-dr-aubrey-de-grey-…e-agingYou can listen to the audio and read the transcript here: https://podcast.boomerliving.tv/dr-aubrey-de-grey-what-cause…-aging/You can listen to many other audio podcasts on our website and Apple Podcasts: https://podcast.boomerliving.tv/
https://podcasts.apple.com/us/podcast/boomer-living-senior-l…1455929808
The detailed physical processes and pathways involved in the transmission of COVID-19 are still not well understood. Researchers decided to use advanced computational fluid dynamics tools on supercomputers to deepen understanding of transmission and provide a quantitative assessment of how different environmental factors influence transmission pathways and airborne infection risk.
SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.
Writing in Nature, a team led by Cambridge researchers report how they were able to observe SARS-CoV-2 mutating in the case of an immunocompromised patient treated with convalescent plasma. In particular, they saw the emergence of a key mutation also seen in the new variant that led to the UK being forced once again into strict lockdown, though there is no suggestion that the variant originated from this patient.
Using a synthetic version of the virus Spike protein created in the lab, the team showed that specific changes to its genetic code — the mutation seen in the B1.1.7 variant — made the virus twice as infectious on cells as the more common strain.